- Effective July 1, 2023, added a prior authorization requirement for anti-diabetic GLP-1 (e.g., Ozempic, Rybelsus, Trulicity, Victoza) and GIP/GLP-1 agonist agents (e.g., Mounjaro) to ensure appropriate prescribing for diabetes under the EUTF active plans.
- Effective October 1, 2023, added quantity limits for anti-platelet products to the EUTF active plans. Existing members using anti-platelet products over the quantity limit will be grandfathered and will not be subject to these quantity limits.
CVS Active Benefits
What’s New?
For EUTF Members
| CVS Plan | July 1, 2024 - June 30, 2025 | July 1, 2023 - June 30, 2024 |
|---|---|---|
| EUTF CVS 90/10 PPO Plan | Summary of Benefits and Coverage Benefits at a Glance | Summary of Benefits and Coverage Benefits at a Glance |
| EUTF CVS 80/20 PPO Plan | Summary of Benefits and Coverage Benefits at a Glance | Summary of Benefits and Coverage Benefits at a Glance |
| EUTF CVS 75/25 PPO Plan | Summary of Benefits and Coverage Benefits at a Glance | Summary of Benefits and Coverage Benefits at a Glance |
| EUTF CVS HMO Plan | Summary of Benefits and Coverage Benefits at a Glance | Summary of Benefits and Coverage Benefits at a Glance |
For HSTA VB Members
| CVS Plan | July 1, 2024 - June 30, 2025 | July 1, 2023 - June 30, 2024 |
|---|---|---|
| HSTA VB CVS 90/10 PPO Plan | Summary of Benefits and Coverage Benefits at a Glance | Summary of Benefits and Coverage Benefits at a Glance |
| HSTA VB CVS 80/20 PPO Plan | Summary of Benefits and Coverage Benefits at a Glance | Summary of Benefits and Coverage Benefits at a Glance |